Xconomy National

Archives

by in

Entry	Author	Date	Location
Cleave Biosciences Nabs $42M, Veteran Execs, to Chase Personalized Cancer Therapies	Luke Timmerman	10/11/11	San Francisco
Cleave Biosciences Receives $42,000,000 Series A Financing Round	VentureDeal	10/11/11	San Francisco
Qualcomm Acquires Video Technologies, State Senate Blocks Brown’s Job Package, Wildcat Expands Funding Round, & More San Diego BizTech News	Bruce V. Bigelow	09/12/11	San Diego
WaveRx Shuts Down: VentureWire	Erin Kutz	08/19/11	Boston
Pulmatrix Snags $14M, Embera Adds for $4.5 Addiction Drugs, Daktari Gets $1.2M, & More Boston-Area Life Sciences News	Erin Kutz	08/19/11	Boston
Carbonite Goes Public At $10 a Share, PeerTransfer Pulls In $7.5M, BuyWithMe Picks Up Scoop St., & More Boston-Area Deals News	Erin Kutz	08/17/11	Boston
Pulmatrix Wins $14M to Back Drug For Cystic Fibrosis And Other Lung Ailments	Arlene Weintraub	08/15/11	Boston
Pulmatrix Secures $14,000,000 Series B Funding	VentureDeal	08/15/11	Boston
DVS Sciences Secures $14,600,000 Series A Funding Round	VentureDeal	07/14/11	San Francisco
VBI Progressing with Vaccines That Don’t Require Refrigeration	Ryan McBride	03/24/11	Boston
Top 10 List of Boston-Area VC Deals for Q4 2010: NinePoint, 1366, Rive, and More	Gregory T. Huang	01/24/11	Boston
DARPA Backs Pulmatrix’s Lung Treatment, Adimab Scores More Pharma Partners, Semprus Secures $18M, & More Boston-Area Life Sciences News	Rebecca Zacks	12/17/10	Boston
BG Medicine Eyes $70M IPO, Nano-Terra Picks Up $17.2M, Rive Technology Raises $25M, & More Boston-Area Deals News	Rebecca Zacks	12/15/10	Boston
Pulmatrix Pulls in $5.7M DARPA Grant to Develop Drug Against Respiratory Threats	Ryan McBride	12/14/10	Boston
Semprus Scores $18M More to Help Improve Medical Devices	Gregory T. Huang	12/13/10	Boston
Anaphore Snags $110M Deal With Mitsubishi Tanabe to Make Drugs for Immune Disorders	Luke Timmerman	12/13/10	San Diego
Semprus BioSciences Lands $18,000,000 Series B Round	VentureDeal	12/13/10	Boston
Pearl Therapeutics, Fresh Off Big VC Round, Tops $3B Lung Drug in Head-to-Head Trial	Luke Timmerman	12/01/10	San Francisco
Phenomix, Former Highflying Diabetes Drugmaker, Shuts Down After Forest Labs Walks	Luke Timmerman	10/26/10	San Diego
Exelixis Seeks to Exit Doghouse, Sangamo Morphs Into Drugmaker, Siluria Adds $13M, & More Bay Area Life Sciences News	Luke Timmerman	10/22/10	San Francisco
Pearl Therapeutics Gets $69M	Luke Timmerman	10/19/10	San Francisco
Pearl Therapeutics Receives $69,000,000 Series C Financing Round	VentureDeal	10/19/10	San Francisco
Synosia Raises $30M, Strikes Deal With UCB Worth Up to $725M for Parkinson’s Drugs	Luke Timmerman	10/12/10	San Francisco
Relypsa Snags $70M Venture Round to Get Rid of Excess Potassium in Blood	Luke Timmerman	09/13/10	San Francisco
Relypsa Obtains $70,000,000 Series B Funding	VentureDeal	09/13/10	San Francisco
Michigan’s Renaissance “Fund of Funds” Closes at Nearly $50M, Ready to Make Connections Between VCs and Entrepreneurs	Howard Lovy	09/07/10	Detroit
Achaogen, Flush with $56M, Seeks to Build Lasting Company with Potent Antibiotics	Luke Timmerman	07/19/10	San Francisco
Ingenuity Systems Adds $15.3M	Luke Timmerman	07/02/10	San Francisco
Incline Therapeutics Secures $43,000,000 Series A Round	VentureDeal	06/22/10	San Francisco
Igenica Lands $24,000,000 Series B Financing Round	VentureDeal	06/11/10	San Francisco
Page 1 of 3	next page »